SJU Commercialization Program
About the program · 1 linked sources
SJU Commercialization Program
The SJU Commercialization Program manages the university's intellectual property portfolio and offers external licensing opportunities. Leveraging research capabilities from the 2022 merger with University of the Sciences (USciences), the program covers drug delivery, oncology, nanotechnology, diabetes/obesity, neurological disorders, and beverage/food science technologies. Contact: Associate Provost for Research and Innovation Jean-Francois Jasmin.
Also known as: Inventions and Discoveries
How we know this: the figures on this page come from the linked sources (last verified 2026-06-24); what those sources do not state is left unknown.
Key numbers
Funding range
Not listed
Equity
None
Application
Ongoing
Campus Wide
Last activity
2026-06-01
Medium confidence
Keep this on your radar Deadline reminders ↓
Reminders
SJU Commercialization Program
Get an email before a director-verified deadline for this program, this school, or this state. The program never sees your address.
Student experiences · Read or add a note
Student notes
SJU Commercialization Program
No posts yet.
Application and Timing
Ongoing. Contact Associate Provost for Research and Innovation.
Participants
Faculty researchers, graduate students, and pharmaceutical science researchers.
Funding and Equity
Not disclosed. Licensing-based commercialization model.
Recent Activity
2026: Program page active with ~18 technologies listed for licensing.
Known Startups or Winners
None publicly listed.
Research gaps & things to verify
Verification Gaps
- No patent counts, licensing revenue, or startup spinout data disclosed
- Program budget and staffing not public
- Likely developing post-USciences merger; maturity unclear
Program details
Technologies
~18 technologies listed for licensing, including:
- Small Molecule GLP-1 Receptor Agonists (diabetes/obesity)
- 3D Printed Bandages (wound healing)
- Bioprinted PATCH Hydrogel (wound healing)
- CAPER Peptides (cancer treatment)
- Novel Yeast Species GY7B (food science)
- 5-HT2A Receptor Agonists (neurological disorders)
Additional research notesShow
Evidence
Official Inventions and Discoveries page on SJU research site.
News & articles
News articles and official sources documenting SJU Commercialization Program at Saint Joseph's University.
1 source
Inventions and Discoveries — SJU Commercialization Program
Saint Joseph's University — Research
Saint Joseph's University — Research
Inventions and Discoveries — SJU Commercialization Program
Official Inventions and Discoveries page. SJU's formal technology transfer/commercialization program, primarily leveraging IP from the 2022 USciences merger. ~18 technologies listed for licensing across drug delivery, oncology, nanotechnology, food science, and neurological disorders. Contact: Associate Provost for Research and Innovation Jean-Francois Jasmin.
Read on Saint Joseph's University — Research